中医药通过调控肠道菌群紊乱防治动脉粥样硬化研究进展  

Research Progress in Prevention and Treatment of Atherosclerosis by Regulating Intestinal Flora Disorder with Traditional Chinese Medicine

作　　者：涂梦婷 郑翠翠 赵瞳 胥玉林 丁桃 万强[2] TU Mengting;ZHENG Cuicui;ZHAO Tong;XU Yulin;DING Tao;WAN Qiang(Jiangxi University of Chinese Medicine,Nanchang 330004,China;The Affiliated Hospital of Jiangxi University of Chinese Medicine,Nanchang 330006,China.)

机构地区：[1]江西中医药大学,南昌330004 [2]江西中医药大学附属医院,南昌330006

出　　处：《江西中医药大学学报》2024年第3期128-132,共5页Journal of Jiangxi University of Chinese Medicine

基　　金：江西省重点研发计划项目(20202BBGL73008);江西省卫生健康委科技计划项目(20201075);江西省教育厅科学技术研究项目(GJJ190654);国家中医药管理局高水平中医药重点学科建设项目(zyyzdxk-2023113)。

摘　　要：关于肠道菌群与动脉粥样硬化的相互关系已经有不少研究报道,并逐渐认为通过调控肠道菌群达到防治动脉粥样硬化是治疗新方向。多种微生物在肠道中拮抗共生,形成微妙的平衡关系,如果某一因素对其平衡产生破坏,可能会引起宿主多种心血管疾病发生。两者之间相互影响的关系,为防治动脉粥样硬化提供新思考,目前研究发现中医药在防治过程中有显著的优势,现将对中医药调控肠道菌群紊乱防治动脉粥样硬化研究进展进行综述。A number of studies have been reported on the interrelationship between intestinal flora and atherosclerosis,and it is gradually considered that the prevention and treatment of atherosclerosis through the regulation of intestinal flora is a new therapeutic direction.The antagonistic symbiosis of multiple microorganisms in the intestinal tract forms a delicate balance,and if a factor disrupts the balance,it may cause the development of multiple cardiovascular diseases in the host.The relationship between the two influences each other,providing new thinking for the prevention and treatment of atherosclerosis.Current research has found that traditional chinese medicine has significant advantages in the prevention and treatment process,so this paper will review the research progress of traditional chinese medicine in regulating intestinal flora disorders to prevent and treat atherosclerosis.

关 键 词：动脉粥样硬化 肠道菌群 中医药 

分 类 号：R256.2[医药卫生—中医内科学]